Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium™

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline Reports Full Year 2021 Financial Results and Business Highlights
Freeline announces supply agreement for haemophilia B program
Freeline to Participate in Upcoming Investor Conferences
Freeline Initiates Dosing of Second Cohort in MARVEL-1 Trial of FLT190 Gene Therapy Candidate for People with Fabry Disease
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels